The QMN Weekly Bulletin
Medical Devices / Inspections and Audits

SPR Therapeutics Blasted for Customer Complaint Handling

May 4, 2018
A A

SPR Therapeutics drew a Form 483 for inadequate complaint handling procedures.

The FDA inspected the firm’s Cleveland, Ohio facility in February 2018. The firm claimed that it had contacted a supplier regarding a complaint and determined the cause was likely a manufacturing issue, but could provide no communication or investigation documentation of it.

It also did not properly establish its supplier qualification and monitoring procedure. It was unclear how its pre-audit questionnaires for suppliers are used and analyzed.

One pre-audit questionnaire answered by a supplier included negative responses on specific quality questions, but the firm did not document its acceptance of the responses or put in place appropriate monitoring activities for the supplier.

View today's stories